Viroclinics Biosciences operates at a global level and is the preferred virology testing laboratory for several of the top 10 biopharmaceutical companies. Our mission is to improve human and animal health by serving the biopharmaceutical community with state-of-the-art diagnostics, custom-made models in (pre)clinical drug testing and expert advice on development of antivirals and vaccines.
The clinical diagnostic testing services support and accelerate the market entry of new drugs, vaccines and antivirals, and assist in pre- and post marketing surveillance programs. Services are customized to specific needs, enabling maximum flexibility from day-to-day analysis to high throughput bulk analysis.read more
The clinical trial operations department is the latest addition to Viroclinics. It provides better logistics support for the pharmaceutical, biotechnology, and medical device industries and gives Viroclinics the opportunity to monitor the quality from the moment the sample is taken to the final test results.read more
Preclinical services include testing of efficacy, safety, PK and (immune) toxicology of drugs, antibodies, vaccines and antivirals targeting viral infectious diseases. The BSL-2 and BSL-3 facilities enable complicated experiments with highly pathogenic viruses. The qualified biotech staff and use of state of the art BSL2 and BSL3 animal facilities are key to a successful outcome of studies.read more
Assay innovation and the introduction of new tools keep analysis up to date with the increasingly demanding criteria for developing new therapeutic and prophylactic candidates up to market registration. Customized assay and protocol development is followed by standardization and validation procedures to allow for routine application in a clinical trial setting.read more
Viroclinics has adopted a high quality standard in all operations, testing procedures and reporting. The quality management system is based on NEN-EN-ISO 15189, expanded with elements of GCP and GLP, to comply with regulatory requirements and facilitate regulatory submissions.read more
Viroclinics participates in global surveillance programs to monitor and characterize novel virus threats to human and animal health (EMPERIE; EU FP-7). Additional research programs focus on genomics, discovery of biomarkers, correlates of protection and viral reference strain development.read more
HIGH QUALITY EXPERT VIROLOGY CONTRACT RESEARCH LABORATORY
Viroclinics Biosciences BV (Viroclinics) operates at a global level, being the preferred virology testing laboratory for several of the top-10 Biopharmaceutical companies. As a virology contract research organization, we serve the biopharmaceutical community with our preclinical, clinical diagnostic, assay development and clinical trial logistics services. Our extensive experience with clinical and preclinical studies for viruses, including our specialty in respiratory viruses, puts us at the forefront for supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases.
Our staff consists of over 60 well-trained, dedicated scientists and technical experts, and our projects are supported by an extensive network of key opinion leaders as consultants. Through an intense collaboration with the Erasmus MC Viroscience Lab, we offer the combined benefits of scientific knowledge and technical ability maintained at both laboratories. This enables Viroclinics Biosciences to support customers with the best virological knowledge available.
Our uniquely consultative approach to business means we nurture deep client relationships in order to fully understand their needs and provide optimally customised research programs and project solutions.
June 2 - June 4
BSL 2 AND BSL 3 FACILITIES AND HIGH QUALITY
Viroclinics Biosciences is a cutting edge lab service organisation with state of the art facilities including laboratory BSL 2 and BSL 3 facilities and a samples processing facility in Boston USA.
Viroclinics has adopted a high quality standard in all operations, testing procedures and reporting. The quality management system is based on NEN-EN-ISO 15189, expanded with elements of GCP and GLP, to comply with regulatory requirements and facilitate regulatory submissions.
Latest Press Release
Viroclinics Biosciences is based in the Netherlands and is proud to announce the addition of a key member of staff to their management team. Paul Zoeteweij has been promoted to Vice President of Business Development. Paul joined Viroclinics in 2007 as a Director of Contracted Research, and soon after as the Director for Clinical Services.read more
Detection of nonhemagglutinating influenza a(h3) viruses by enzyme-linked immunosorbent assay in quantitative influenza virus culture.read more
We need you!
At the moment we have no vacancies, but we are always open to contact other highly qualified and motivated individuals too. If you have completed a relevant education, have experience within the health and life sciences industry, and you would like to work in a dynamic contract research organization, please let us know. You are invited to send an open application letter and curriculum vitae to firstname.lastname@example.org more